INDV Indivior plc: Net earnings per share for the last 12 months

Public company logo of Indivior plc (INDV)

Indivior PLC (INDV) generates revenue from Sublocade patents, ensuring high margins due to low-cost injection production. The rolling change in earnings per share YoY reflects yield dynamics, where the value 265.50 serves as the baseline indicator. However, regulatory pressure and generic risks require management to promptly expand the drug portfolio to maintain business resilience.

INDV Indivior plc: Earnings per share for the last twelve months in the range 11/23/2025 - 11/14/2026

indivior.com - analytical breakdowns and key metrics (INDV)

- current price and projected stock value:
Price Performance Chart Indivior plc|INDV - Price Target Chart
- company stock capitalization data:
Market Valuation Indivior Group|INDV - Enterprise Value
- book capitalization data:
Net Assets per Share Indivior|INDV - Company Book Value|Capitalization to Book Value Ratio indivior.com|INDV - Company Total Assets
- company total debt and liquidity indicators:
Debt to Equity Ratio Indivior PLC|INDV - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Indivior|INDV - Company Total Debt|Debt to Book Capitalization Ratio Indivior Group|INDV - Company Long-Term Debts|Short-Term Debt Volume Indivior|Immediate Liquidity indivior.com
- business earnings and investment ratios data:
INDV - Company Net Income|Expected Net Income Indivior PLC|INDV - Price to Earnings Ratio|Future Price to Earnings Multiple Indivior Corp|INDV - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Indivior Corp|INDV - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Indivior|INDV - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months indivior.com|INDV - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Indivior PLC
- revenue and sales details:
INDV - Company Revenue|Company Revenue Forecast Indivior|INDV - P/S Multiple|Market Cap to Projected Revenue Indivior|INDV - Revenue Growth YoY (Last 12 Months)
Fundamental valuation:Indivior - INDV
Finished products of Indivior PLC

Indivior PLC investments in environmental plant upgrades and filtration systems directly impact capital expenditures, which in turn affects net income. The trailing twelve-month (TTM) earnings per share dynamics compare the current rolling year with the previous one, allowing the eps YoY ttm shift metric to assess real business efficiency without quarterly lags.

Competitor analysis for Indivior PLC

Earnings per share for the trailing year COLL (Collegium Pharma)|Cronos Corp (CRON) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Tweed|HITI (High Tide Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) auroramj.com|Net earnings per share (EPS TTM) ACHV|Net earnings per share (EPS TTM) Skye Bioscience (SKYE)|Net earnings per share (EPS TTM) ANEB (anebulo.com)|Earnings per share for the last four quarters INCR (Canndoc)|NTRB - Earnings per share for the last twelve months|NSRX - Net earnings per share (EPS TTM)|IGC: Net earnings per share (EPS TTM)|MIRA Pharma - Earnings per share for the trailing year|Net earnings per share for the last 12 months FLGC|Earnings per share for the last 12 months IMCC (imcannabis.com)|Earnings per share for the last twelve months adialpharma.com (ADIL)|ARTL (Artelo Biosciences, Inc.) - Earnings per share for the trailing year|Ensysce Biosciences - Net earnings per share for the last 12 months|Earnings per share for the trailing year TTNP|gnln.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year INM (InMed)|Akanda Corp. (AKAN) - Earnings per share for the last twelve months|ENVB - Net earnings per share for the last four quarters|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO